Filing Details
- Accession Number:
- 0001628280-24-050104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-05 17:02:35
- Reporting Period:
- 2024-11-01
- Accepted Time:
- 2024-12-05 17:02:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 1600 West End Ave., Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-01 | 380 | $1.15 | 263,978 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-04 | 245 | $1.17 | 264,223 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-05 | 380 | $1.20 | 264,603 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-06 | 380 | $1.20 | 264,983 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-07 | 380 | $1.17 | 265,363 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-08 | 380 | $1.18 | 265,743 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-11 | 380 | $1.20 | 266,123 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-12 | 380 | $1.20 | 266,503 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-13 | 380 | $1.20 | 266,883 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-14 | 380 | $1.19 | 267,263 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-15 | 380 | $1.17 | 267,643 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-18 | 380 | $1.18 | 268,023 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-19 | 380 | $1.15 | 268,403 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-20 | 427 | $1.13 | 268,830 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-21 | 427 | $1.09 | 269,257 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-22 | 474 | $1.07 | 269,731 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-25 | 474 | $1.09 | 270,205 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-26 | 474 | $1.11 | 270,679 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-27 | 474 | $1.15 | 271,153 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-29 | 474 | $1.32 | 271,627 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
Billionaire Hedge Funds
